Fig. 5From: Real-world outcomes in hereditary angioedema: first experience from the Icatibant Outcome Survey in the United KingdomProportion of HAE attacks treated with icatibant by self-administration or administration by HCPs per attack in the UK and non-UK patients. HAE hereditary angioedema, HCP healthcare professionalBack to article page